http://rdf.ncbi.nlm.nih.gov/pubchem/reference/620807

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1604
issn 0167-6997
1573-0646
issueIdentifier 5
pageRange 1601-1604
publicationName Investigational New Drugs
startingPage 1601
bibliographicCitation Lavoie JM, Mitchell T, Lee SE, Deol B, Chia SK, Gelmon KA, Kollmannsberger CK, Tinker AV, Jones SJM, Marra M, Laskin J, Renouf DJ. Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis. Invest New Drugs. 2020 Oct;38(5):1601–4. doi: 10.1007/s10637-020-00892-8. PMID: 31907737.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b598da6cb146639edd61b5fd1b6eabc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d44d0cf8b473b8c7aabd01bcc583e199
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b76236fc33365b621c5b84a4b980c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22792818cb862485cbda9bff4e0be13d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a84075dff263cd9163970a886a2df64a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5344-8341
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e45f2daadc710e132cea4961244c4c9d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e2c09ed9d837904cb7b9c536efa9371
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dd1b91dad7457e791723ed0258855d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f209ac3f63b1bfd7bb79212b11f1301
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5dca415721fcc4556e7e23fb8452214
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cabc57cfab8469094e5cad553a071b7d
date 2020-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/31907737
https://doi.org/10.1007/s10637-020-00892-8
isPartOf https://portal.issn.org/resource/ISSN/0167-6997
https://portal.issn.org/resource/ISSN/1573-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11

Total number of triples: 34.